Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up CRGO Q1 2026 Earnings EPS Misses Estimates as Stock Declines on WiderThanExpected Loss TONX Q1 2026 Earnings Significant EPS Beat Drives 458 Stock Gain EMPD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower EML Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Reaction RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges